Accel-Heal Technologies Limited
Developer of a single-use, wearable microcurrent electrical stimulation therapy platform for painful and hard-to-heal wounds. The platform delivers a preprogrammed 12-day automated therapy intended for use alongside standard wound care in clinic or at home. The company publishes clinical and health-economic evidence (RCTs, meta-analyses, real-world evaluations) supporting pain reduction, improved healing rates, quality-of-life gains and cost savings, and engages with clinical advisors, KOLs and health systems for adoption and reimbursement.
Industries
Nr. of Employees
small (1-50)
Accel-Heal Technologies Limited
Kent, Kent, United Kingdom, Europe
Products
Wearable single-use 12-day preprogrammed microcurrent electrostimulation device
A disposable, wearable device that delivers a fixed 12-day microcurrent stimulation therapy intended to reduce wound pain and promote healing; designed for use in clinic or at home alongside standard dressings and compression where appropriate.
Wearable single-use 12-day preprogrammed microcurrent electrostimulation device
A disposable, wearable device that delivers a fixed 12-day microcurrent stimulation therapy intended to reduce wound pain and promote healing; designed for use in clinic or at home alongside standard dressings and compression where appropriate.
Services
Webinars and masterclasses introducing electrical stimulation therapy, presenting clinical evidence and guidance for integration into standard care.
Support for regional distribution agreements and participation in public procurement/tender processes.
Webinars and masterclasses introducing electrical stimulation therapy, presenting clinical evidence and guidance for integration into standard care.
Support for regional distribution agreements and participation in public procurement/tender processes.
Expertise Areas
- Wound care electrical stimulation therapy
- Clinical trial and real-world evidence generation
- Health economic evaluation for wound care
- Wearable medical device design for home use
Key Technologies
- Microcurrent electrical stimulation
- Preprogrammed wearable electrostimulation devices
- Embedded therapy control systems
- Patient-reported outcome measurement
News & Updates
Summary of new clinical and health-economic evaluations presented at Wounds UK showing accelerated healing, pain reduction and QoL improvements.
Announcement of award of a public tender following clinical evaluation and review of scientific and economic evidence.
Regional distribution agreement announced to make the therapy available across Denmark, Sweden, Norway and Finland.
Summary and commentary on a study reporting reduced bioelectric signalling in older people and those with diabetes.
Selected through a tender process following clinical evaluation and evidence review.
Introduced a single wearable device capable of delivering the full 12-day programmed therapy (replacing prior multi-device regimen).
Summary of new clinical and health-economic evaluations presented at Wounds UK showing accelerated healing, pain reduction and QoL improvements.
Announcement of award of a public tender following clinical evaluation and review of scientific and economic evidence.
Regional distribution agreement announced to make the therapy available across Denmark, Sweden, Norway and Finland.
Summary and commentary on a study reporting reduced bioelectric signalling in older people and those with diabetes.
Selected through a tender process following clinical evaluation and evidence review.
Introduced a single wearable device capable of delivering the full 12-day programmed therapy (replacing prior multi-device regimen).